Summit Investment Advisors »

Theravance Biopharma shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $68k 6.1k 11.24
2023-09-30 $53k 6.1k 8.63
2023-06-30 $48k 4.6k 10.35
2023-03-31 $50k 4.6k 10.85
2022-12-31 $51k 4.6k 10.90
2022-09-30 $47k 4.6k 10.14
2022-06-30 $42k 4.6k 9.06
2022-03-31 $44k 4.6k 9.49
2021-12-31 $51k 4.6k 11.00
2021-09-30 $28k 3.8k 7.38
2021-06-30 $55k 3.8k 14.50
2021-03-31 $77k 3.8k 20.30
2020-12-31 $76k 4.3k 17.75
2020-09-30 $63k 4.3k 14.71
2020-06-30 $90k 4.3k 21.02
2020-03-31 $92k 4.0k 23.16
2019-12-31 $95k 3.7k 25.91
2019-09-30 $71k 3.7k 19.37
2019-06-30 $60k 3.7k 16.37
2019-03-31 $83k 3.7k 22.64
2018-12-31 $94k 3.7k 25.64
2018-09-30 $120k 3.7k 32.73
2018-06-30 $83k 3.7k 22.64
2018-03-31 $89k 3.7k 24.28
2017-12-31 $932k 3.9k 241.21
2017-09-30 $117k 3.9k 30.15
2017-06-30 $136k 3.9k 35.18
2017-03-31 $128k 3.6k 35.09
2016-12-31 $7.0k 228 30.70
2016-09-30 $8.0k 228 35.09
2016-06-30 $5.0k 228 21.93
2016-03-31 $4.0k 228 17.54
2015-12-31 $3.0k 228 13.16